1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Anybody know anything about hospice sales?

Discussion in 'HIV reps' started by Anonymous, Mar 19, 2009 at 12:16 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Hoping it's a step up from Pharma

  2. Anonymous

    Anonymous Guest

    I had a former big pharma partner who was a President's Club winner several times over who left the industry for a few years to enjoy life. She entered back into the work force in hospice care sales and loved it. Her husband took a transfer after a year so she left the hospice industry but said that her year in it was great and it didn't include a lot of the headaches that we had in pharma.

    I know this post is a bit delayed - best of luck.
  3. Anonymous

    Anonymous Guest

    I wouldn't say hospice is a step up from pharma. Pay is a little less or about the same depending on what type of pharma (60-70 K base) and maybe 20 K commission. Watch out if it's Gentiva...they burn thru reps high turnover
  4. anonymous

    anonymous Guest

    ive heard it is kinda a dead business?